Common variants on chromosome 9p21 are associated with normal tension Glaucoma

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Takamoto, Mitsuko ^a   Kaburaki, Toshikatsu ^a   Mabuchi, Akihiko ^a   Araie, Makoto ^a   Amano, Shiro ^a   Aihara, Makoto ^a   Tomidokoro, Atsuo ^a   Iwase, Aiko ^b,c   Mabuchi, Fumihiko ^d   Kashiwagi, Kenji ^d   Shirato, Shiroaki ^e   Yasuda, Noriko ^f   Kawashima, Hidetoshi ^g   Nakajima, Fumiko ^g,h   Numaga, Jiro ⁱ   Kawamura, Yoshiya ^j   Sasaki, Tsukasa ^k   Tokunaga, Katsushi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Tajimi Municipal Hospital   (Japan)

^c Tajimi Iwase Eye Clinic   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e Shirato Eye Clinic   (Japan)

^f TOKYO METROPOLITAN POLICE HOSPITAL   (Japan)

^g SAITAMA RED CROSS HOSPITAL   (Japan)

^h Showa General Hospital   (Japan)

ⁱ Tokyo Metropolitan Institute of Gerontology   (Japan)

^j Yokohama Clinic   (Japan)

^k UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CDKNB2 GENE; CHROMOSOME 9P; CHROMOSOME VARIANT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; INTRAOCULAR PRESSURE; JAPANESE; LOW TENSION GLAUCOMA; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; LOW TENSION GLAUCOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84863614114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040107     Document Type: Article

References (93)

1. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME, (1997) TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 115: 1031-1035.
2. Quigley HA, Addicks EM, (1981) Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol 99: 137-143.
3. Quigley HA, Broman AT, (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90: 262-267.
4. Allingham RR, Shields MB, (2005) Shields' textbook of glaucoma. Philadelphia: Lippincott Willliams & Wilkins. xiii, 702 p.
5. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, et al. (2003) Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121: 48-56.
6. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, et al. (2002) The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120: 701-713.
7. Collaborative Normal-Tension Glaucoma Study Group (1998) The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126: 498-505.
8. The AGIS Investigators, (2000) The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130: 429-440.
9. Airaksinen PJ, Mustonen E, Alanko HI, (1981) Optic disc hemorrhages. Analysis of stereophotographs and clinical data of 112 patients. Arch Ophthalmol 99: 1795-1801.
10. Gloster J, (1981) Incidence of optic disc haemorrhages in chronic simple glaucoma and ocular hypertension. Br J Ophthalmol 65: 452-456.
11. Kitazawa Y, Shirato S, Yamamoto T, (1986) Optic disc hemorrhage in low-tension glaucoma. Ophthalmology 93: 853-857.
12. Barry CJ, Cooper RL, Eikelboom RH, (1997) Optic disc haemorrhages and vascular abnormalities in a glaucoma population. Aust N Z J Ophthalmol 25: 137-144.
13. Yamazaki Y, Koide C, Miyazawa T, Kuwagaki N, Yamada H, (1991) Comparison of retinal nerve-fiber layer in high- and normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 229: 517-520.
14. Chihara E, Tanihara H, (1992) Parameters associated with papillomacular bundle defects in glaucoma. Graefes Arch Clin Exp Ophthalmol 230: 511-517.
15. Yamagami J, Araie M, Shirato S, (1992) A comparative study of optic nerve head in low- and high-tension glaucomas. Graefes Arch Clin Exp Ophthalmol 230: 446-450.
16. Tezel G, Kass MA, Kolker AE, Wax MB, (1996) Comparative optic disc analysis in normal pressure glaucoma, primary open-angle glaucoma, and ocular hypertension. Ophthalmology 103: 2105-2113.
17. Eid TE, Spaeth GL, Moster MR, Augsburger JJ, (1997) Quantitative differences between the optic nerve head and peripapillary retina in low-tension and high-tension primary open-angle glaucoma. Am J Ophthalmol 124: 805-813.
18. Junemann AG, Martus P, Wisse M, Jonas J, (2000) Quantitative analysis of visual field and optic disk in glaucoma: retinal nerve fiber bundle-associated analysis. Graefes Arch Clin Exp Ophthalmol 238: 306-314.
19. Dong J, Chihara E, (2001) Slope analysis of the optic disc in eyes with ocular hypertension and early normal tension glaucoma by confocal scanning laser ophthalmoscope. Br J Ophthalmol 85: 56-62.
20. Woo SJ, Park KH, Kim DM, (2003) Comparison of localised nerve fibre layer defects in normal tension glaucoma and primary open angle glaucoma. Br J Ophthalmol 87: 695-698.
21. Morgan-Davies J, Taylor N, Hill AR, Aspinall P, O'Brien CJ, et al. (2004) Three dimensional analysis of the lamina cribrosa in glaucoma. Br J Ophthalmol 88: 1299-1304.
22. Wax MB, Tezel G, (2009) Immunoregulation of retinal ganglion cell fate in glaucoma. Exp Eye Res 88: 825-830.
23. Joachim SC, Pfeiffer N, Grus FH, (2005) Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens. Graefes Arch Clin Exp Ophthalmol 243: 817-823.
24. Kremmer S, Kreuzfelder E, Klein R, Bontke N, Henneberg-Quester KB, et al. (2001) Antiphosphatidylserine antibodies are elevated in normal tension glaucoma. Clin Exp Immunol 125: 211-215.
25. Romano C, Barrett DA, Li Z, Pestronk A, Wax MB, (1995) Anti-rhodopsin antibodies in sera from patients with normal-pressure glaucoma. Invest Ophthalmol Vis Sci 36: 1968-1975.
26. Tezel G, Seigel GM, Wax MB, (1998) Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci 39: 2277-2287.
27. Meyer JH, Brandi-Dohrn J, Funk J, (1996) Twenty four hour blood pressure monitoring in normal tension glaucoma. Br J Ophthalmol 80: 864-867.
28. Riccadonna M, Covi G, Pancera P, Presciuttini B, Babighian S, et al. (2003) Autonomic system activity and 24-hour blood pressure variations in subjects with normal- and high-tension glaucoma. J Glaucoma 12: 156-163.
29. Kaiser HJ, Flammer J, Graf T, Stumpfig D, (1993) Systemic blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol 231: 677-680.
30. Cursiefen C, Wisse M, Cursiefen S, Junemann A, Martus P, et al. (2000) Migraine and tension headache in high-pressure and normal-pressure glaucoma. Am J Ophthalmol 129: 102-104.
31. Phelps CD, Corbett JJ, (1985) Migraine and low-tension glaucoma. A case-control study. Invest Ophthalmol Vis Sci 26: 1105-1108.
32. Schwenn O, Troost R, Vogel A, Grus F, Beck S, et al. (2002) Ocular pulse amplitude in patients with open angle glaucoma, normal tension glaucoma, and ocular hypertension. Br J Ophthalmol 86: 981-984.
33. Harris A, Sergott RC, Spaeth GL, Katz JL, Shoemaker JA, et al. (1994) Color Doppler analysis of ocular vessel blood velocity in normal-tension glaucoma. Am J Ophthalmol 118: 642-649.
34. Rojanapongpun P, Drance SM, Morrison BJ, (1993) Ophthalmic artery flow velocity in glaucomatous and normal subjects. Br J Ophthalmol 77: 25-29.
35. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, et al. (1991) Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 266: 369-374.
36. Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, et al. (1992) Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 99: 1499-1504.
37. Coffey M, Reidy A, Wormald R, Xian WX, Wright L, et al. (1993) Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol 77: 17-21.
38. Rotchford AP, Kirwan JF, Muller MA, Johnson GJ, Roux P, (2003) Temba glaucoma study: a population-based cross-sectional survey in urban South Africa. Ophthalmology 110: 376-382.
39. Dielemans I, de Jong PT, Stolk R, Vingerling JR, Grobbee DE, et al. (1996) Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study. Ophthalmology 103: 1271-1275.
40. Kim CS, Seong GJ, Lee NH, Song KC, (2011) Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology 118: 1024-1030.
41. Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, et al. (2004) The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 111: 1641-1648.
42. Wolfs RC, Klaver CC, Ramrattan RS, van Duijn CM, Hofman A, et al. (1998) Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol 116: 1640-1645.
43. Sarfarazi M, Child A, Stoilova D, Brice G, Desai T, et al. (1998) Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region. Am J Hum Genet 62: 641-652.
44. Rezaie T, Child A, Hitchings R, Brice G, Miller L, et al. (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295: 1077-1079.
45. Alward WL, Kwon YH, Kawase K, Craig JE, Hayreh SS, et al. (2003) Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma. Am J Ophthalmol 136: 904-910.
46. Funayama T, Ishikawa K, Ohtake Y, Tanino T, Kurosaka D, et al. (2004) Variants in optineurin gene and their association with tumor necrosis factor-alpha polymorphisms in Japanese patients with glaucoma. Invest Ophthalmol Vis Sci 45: 4359-4367.
47. Sripriya S, Nirmaladevi J, George R, Hemamalini A, Baskaran M, et al. (2006) OPTN gene: profile of patients with glaucoma from India. Mol Vis 12: 816-820.
48. Fan BJ, Wang DY, Fan DS, Tam PO, Lam DS, et al. (2005) SNPs and interaction analyses of myocilin, optineurin, and apolipoprotein E in primary open angle glaucoma patients. Mol Vis 11: 625-631.
49. Vickers JC, Craig JE, Stankovich J, McCormack GH, West AK, et al. (2002) The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis 8: 389-393.
50. Lam CY, Fan BJ, Wang DY, Tam PO, Yung Tham CC, et al. (2006) Association of apolipoprotein E polymorphisms with normal tension glaucoma in a Chinese population. J Glaucoma 15: 218-222.
51. Aung T, Ocaka L, Ebenezer ND, Morris AG, Brice G, et al. (2002) Investigating the association between OPA1 polymorphisms and glaucoma: comparison between normal tension and high tension primary open angle glaucoma. Hum Genet 110: 513-514.
52. Mabuchi F, Tang S, Kashiwagi K, Yamagata Z, Iijima H, et al. (2007) The OPA1 gene polymorphism is associated with normal tension and high tension glaucoma. Am J Ophthalmol 143: 125-130.
53. Powell BL, Toomes C, Scott S, Yeung A, Marchbank NJ, et al. (2003) Polymorphisms in OPA1 are associated with normal tension glaucoma. Mol Vis 9: 460-464.
54. Shibuya E, Meguro A, Ota M, Kashiwagi K, Mabuchi F, et al. (2008) Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma. Invest Ophthalmol Vis Sci 49: 4453-4457.
55. Meguro A, Inoko H, Ota M, Mizuki N, Bahram S, (2010) Genome-wide association study of normal tension glaucoma: common variants in SRBD1 and ELOVL5 contribute to disease susceptibility. Ophthalmology 117: 1331-1338 e1335.
56. Mabuchi F, Sakurada Y, Kashiwagi K, Yamagata Z, Iijima H, et al. (2011) Association between SRBD1 and ELOVL5 gene polymorphisms and primary open-angle glaucoma. Invest Ophthalmol Vis Sci 52: 4626-4629.
57. Thorleifsson G, Walters GB, Hewitt AW, Masson G, Helgason A, et al. (2010) Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet 42: 906-909.
58. Burdon KP, Macgregor S, Hewitt AW, Sharma S, Chidlow G, et al. (2011) Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet.
59. Nakano M, Ikeda Y, Taniguchi T, Yagi T, Fuwa M, et al. (2009) Three susceptible loci associated with primary open-angle glaucoma identified by genome-wide association study in a Japanese population. Proc Natl Acad Sci U S A 106: 12838-12842.
60. Ramdas WD, van Koolwijk LM, Lemij HG, Pasutto F, Cree AJ, et al. (2011) Common genetic variants associated with open-angle glaucoma. Hum Mol Genet 20: 2464-2471.
61. Fan BJ, Wang DY, Pasquale LR, Haines JL, Wiggs JL, (2011) Genetic Variants Associated with Optic Nerve Vertical Cup-to-Disc Ratio Are Risk Factors for Primary Open Angle Glaucoma in a US Caucasian Population. Invest Ophthalmol Vis Sci 52: 1788-1792.
62. Ramdas WD, van Koolwijk LM, Ikram MK, Jansonius NM, de Jong PT, et al. (2010) A genome-wide association study of optic disc parameters. PLoS Genet 6: e1000978.
63. Nakano M, Ikeda Y, Tokuda Y, Fuwa M, Omi N, et al. (2012) Common Variants in CDKN2B-AS1 Associated with Optic-Nerve Vulnerability of Glaucoma Identified by Genome-Wide Association Studies in Japanese. PLoS One 7: e33389.
64. Canepa ET, Scassa ME, Ceruti JM, Marazita MC, Carcagno AL, et al. (2007) INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life 59: 419-426.
65. Pho L, Grossman D, Leachman SA, (2006) Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma. Curr Opin Oncol 18: 173-179.
66. Kim WY, Sharpless NE, (2006) The regulation of INK4/ARF in cancer and aging. Cell 127: 265-275.
67. Hannon GJ, Beach D, (1994) p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371: 257-261.
68. Duenker N, (2005) Transforming growth factor-beta (TGF-beta) and programmed cell death in the vertebrate retina. Int Rev Cytol 245: 17-43.
69. Pena JD, Taylor AW, Ricard CS, Vidal I, Hernandez MR, (1999) Transforming growth factor beta isoforms in human optic nerve heads. Br J Ophthalmol 83: 209-218.
70. Fuchshofer R, (2011) The pathogenic role of transforming growth factor-beta2 in glaucomatous damage to the optic nerve head. Exp Eye Res 93: 165-169.
71. Trivedi RH, Nutaitis M, Vroman D, Crosson CE, (2011) Influence of race and age on aqueous humor levels of transforming growth factor-Beta 2 in glaucomatous and nonglaucomatous eyes. J Ocul Pharmacol Ther 27: 477-480.
72. Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, et al. (2001) TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 3: 400-408.
73. Ohsaka Y, Yogosawa S, Nakanishi R, Sakai T, Nishino H, (2010) Polymorphisms in promoter sequences of the p15 (INK4B) and PTEN genes of normal Japanese individuals. Biochem Genet 48: 970-986.
74. Gil J, Peters G, (2006) Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7: 667-677.
75. Levkovitch-Verbin H, Dardik R, Vander S, Nisgav Y, Kalev-Landoy M, et al. (2006) Experimental glaucoma and optic nerve transection induce simultaneous upregulation of proapoptotic and prosurvival genes. Invest Ophthalmol Vis Sci 47: 2491-2497.
76. Pasmant E, Sabbagh A, Vidaud M, Bieche I, (2011) ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 25: 444-448.
77. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, et al. (2008) The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 40: 217-224.
78. Uno S, Zembutsu H, Hirasawa A, Takahashi A, Kubo M, et al. (2010) A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat Genet 42: 707-710.
79. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, et al. (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41: 905-908.
80. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899-904.
81. Visel A, Zhu Y, May D, Afzal V, Gong E, et al. (2010) Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464: 409-412.
82. Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z, et al. (2010) Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet 6: e1001233.
83. Doughty MJ, Zaman ML, (2000) Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol 44: 367-408.
84. Wu LL, Suzuki Y, Ideta R, Araie M, (2000) Central corneal thickness of normal tension glaucoma patients in Japan. Jpn J Ophthalmol 44: 643-647.
85. Anderson DR, Patella VM, (1999) Automated static perimetry. St. Louis: Mosby. xiv, 363 p. p.
86. Nishida N, Koike A, Tajima A, Ogasawara Y, Ishibashi Y, et al. (2008) Evaluating the performance of Affymetrix SNP Array 6.0 platform with 400 Japanese individuals. BMC Genomics 9: 431.
87. Kawamura Y, Otowa T, Koike A, Sugaya N, Yoshida E, et al. (2011) A genome-wide CNV association study on panic disorder in a Japanese population. J Hum Genet 56: 852-856.
88. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
89. Nishida N, Tanabe T, Takasu M, Suyama A, Tokunaga K, (2007) Further development of multiplex single nucleotide polymorphism typing method, the DigiTag2 assay. Anal Biochem 364: 78-85.
90. Cunnington MS, Santibanez Koref M, Mayosi BM, Burn J, Keavney B, (2010) Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet 6: e1000899.
91. Wigginton JE, Cutler DJ, Abecasis GR, (2005) A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76: 887-893.
92. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
93. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.